摘要
目前,胰岛素及其类似物治疗糖尿病进展显著。随着对糖尿病类型的不断深入分析,胰岛素及其类似物已成为糖尿病治疗的主要手段。短效胰岛素、速效胰岛素、长效胰岛素、混合型胰岛素等胰岛素剂型问世,显著提高治疗效果和患者依从性。胰岛素类似物新剂型有依柯胰岛素、依西托拉胰岛素、胰高血糖素样肽-1受体激动剂等,可控制餐后血糖水平,减轻体重,进一步降低葡萄糖进入血中的速率。未来,胰岛素治疗领域将继续优化和创新。
At present,insulin and its analogues have made significant progress in the treatment of diabetes.With the continuous in-depth analysis of the types of diabetes,insulin and its analogues have become the main means of diabetes treatment.Short-acting insulin,fast-acting insulin,long-acting insulin,mixed insulin and other insulin dosage forms have been available,which significantly improve the treatment effect and patient compliance.The new dosage forms of insulin analogues include Icodec insulin,Efsitora insulin,glucagon-like peptide-1 receptor agonists,etc.,which can control postprandial blood glucose levels,reduce body weight,and further reduce the rate of glucose entering the blood.In the future,the field of insulin therapy will continue to be optimized and innovated.
作者
何子英
汪瑾
许铮铮
HE Ziying;WANG Jin;XU Zhengzheng(Department of Comprehensive,Third People's Hospital of Tongling City,Tongling 244000,Anhui,China)
出处
《糖尿病新世界》
2025年第9期195-198,共4页
Diabetes New World
关键词
糖尿病
胰岛素
治疗效果
餐后血糖水平
治疗领域
Diabetes
Insulin
Therapeutic effect
Postprandial blood glucose levels
Therapy area
作者简介
何子英(1988-),女,本科,主治医师,研究方向为慢性病防治。
